Amgen’s R&D chief talks about future of Alzheimer’s research

Amgen’s R&D chief talks about future of Alzheimer’s research

STAT Plus: Amgen’s R&D chief on the ‘slow-moving tsunami’ of Alzheimer’s and the future of disease research

By MEGAN THIELKING

ALEX HOGAN/STAT

Dr. David Reese, Amgen's head of research and development, spoke with STAT about Alzheimer's research, the amyloid hypothesis, and drug pricing.

READ MORE